Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Knauf

Showing results (781-790 of 868) with videos related to

Pageof 87
Sort By:
Blood|April 12, 2012
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trialPeter Dreger, Hartmut Döhner, Fabienne McClanahan, et al.
Emerging Infectious Diseases|April 19, 2017
Survey of Treponemal Infections in Free-Ranging and Captive Macaques, 1999-2012Amy R Klegarth, Chigozie A Ezeonwu, Aida Rompis, et al.
Molecular Cancer Research : MCR|February 9, 2019
Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as DriversRebecca E Schweppe, Nikita Pozdeyev, Laura A Pike, et al.
Cancers|October 14, 2022
BRAF<sup>V600E</sup> Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 MacrophagesCatherine Spourquet, Ophélie Delcorte, Pascale Lemoine, et al.
The Journal of Clinical Investigation|September 27, 2016
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodineJames Nagarajah, Mina Le, Jeffrey A Knauf, et al.
Plos One|June 11, 2009
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisVanessa Deveaux, Thomas Cadoudal, Yasukatsu Ichigotani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2007
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology StudyMichael Herold, Antje Haas, Stefanie Srock, et al.
JMIR Research Protocols|November 30, 2023
Design Research to Embed mHealth into a Community-Led Blood Pressure Management System in Uganda: Protocol for a Mixed Methods StudyJosephine Schwab, Jonas Wachinger, Richard Munana, et al.
Gut|September 26, 2020
Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitisJulien Pujo, Camille Petitfils, Pauline Le Faouder, et al.
British Journal of Haematology|September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupM Hallek, B Schmitt, M Wilhelm, et al.
Pageof 87

Showing results (781-790 of 868) with videos related to

Sort By:
Pageof 87
Blood|April 12, 2012
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trialPeter Dreger, Hartmut Döhner, Fabienne McClanahan, et al.
Emerging Infectious Diseases|April 19, 2017
Survey of Treponemal Infections in Free-Ranging and Captive Macaques, 1999-2012Amy R Klegarth, Chigozie A Ezeonwu, Aida Rompis, et al.
Molecular Cancer Research : MCR|February 9, 2019
Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as DriversRebecca E Schweppe, Nikita Pozdeyev, Laura A Pike, et al.
Cancers|October 14, 2022
BRAF<sup>V600E</sup> Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 MacrophagesCatherine Spourquet, Ophélie Delcorte, Pascale Lemoine, et al.
The Journal of Clinical Investigation|September 27, 2016
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodineJames Nagarajah, Mina Le, Jeffrey A Knauf, et al.
Plos One|June 11, 2009
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisVanessa Deveaux, Thomas Cadoudal, Yasukatsu Ichigotani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2007
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology StudyMichael Herold, Antje Haas, Stefanie Srock, et al.
JMIR Research Protocols|November 30, 2023
Design Research to Embed mHealth into a Community-Led Blood Pressure Management System in Uganda: Protocol for a Mixed Methods StudyJosephine Schwab, Jonas Wachinger, Richard Munana, et al.
Gut|September 26, 2020
Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitisJulien Pujo, Camille Petitfils, Pauline Le Faouder, et al.
British Journal of Haematology|September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupM Hallek, B Schmitt, M Wilhelm, et al.
Pageof 87